Institution statistics - INNOVATION

KAROLINSKA INSTITUTE - Sweden 

Ranking results:

Past rankings:
Subject specific rankings are not yet available..
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 INNOVATION):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 40
As coordinator: 11
As participant: 23
Sole participant: 6
Coordinator / Participant Ratio: 0.48*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2011 0 3.914.345 546.589 2
2010 3.782.107 399.600 1.681.547 5 1
2008 2.946.420 10.921.350 1.065.878 1 1
2007 0 6.092.772 739.145 3
2006 297.300 10.821.480 1.235.394 2 5
2005 1.879.800 0 268.543 1
2004 931.749 12.174.994 759.650 3 3
2003 0 1.604.661 267.444 1
2002 3.572.690 4.452.941 1.361.564 2 3
2001 0 5.932.049 799.400 3
2000 1.528.868 2.399.729 895.834 3 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE140
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE113
UNIVERSITY COLLEGE LONDON90
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE88
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD78
UNIVERSITY OF HELSINKI68
KING'S COLLEGE LONDON65
MEDICAL RESEARCH COUNCIL57
INSTITUT PASTEUR55
UPPSALA UNIVERSITET55
KATHOLIEKE UNIVERSITEIT LEUVEN51
STICHTING KATHOLIEKE UNIVERSITEIT50
EUROPEAN MOLECULAR BIOLOGY LABORATORY48
COMMISSARIAT A L'ENERGIE ATOMIQUE46
CHARITE UNIVERSITAETSMEDIZIN BERLIN45
ISTITUTO SUPERIORE DI SANITA43
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE41
THE UNIVERSITY OF EDINBURGH41
UNIVERSITY OF COPENHAGEN41
UNIVERSITY OF OSLO38
THE UNIVERSITY OF MANCHESTER37
UNIVERSITAET ZUERICH37
LUNDS UNIVERSITET35
WEIZMANN INSTITUTE OF SCIENCE35
LEIDEN UNIVERSITY MEDICAL CENTER34
UNIVERSITEIT UTRECHT34
UNIVERSITY OF GLASGOW34
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT33
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS32
CONSIGLIO NAZIONALE DELLE RICERCHE32
UNIVERSITA DEGLI STUDI DI MILANO32
UNIVERSITEIT GENT32
UNIVERSITE DE GENEVE31
UNIVERSITEIT MAASTRICHT30
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN29
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV29
UNIVERSITY OF BIRMINGHAM29
UNIVERSITY OF LEEDS29
KUNGLIGA TEKNISKA HOEGSKOLAN28
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS28
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE27
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM27
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V26
TARTU ULIKOOL25
UNIVERSITY OF BERGEN25
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS24
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH23
THE HEBREW UNIVERSITY OF JERUSALEM23
UNIVERSITAETSKLINIKUM HEIDELBERG23
UNIVERSITAIR MEDISCH CENTRUM UTRECHT23
UNIVERSITY OF NEWCASTLE UPON TYNE23
DEUTSCHES KREBSFORSCHUNGSZENTRUM22
HEINRICHHEINEUNIVERSITAET DUESSELDORF22
REGION HOVEDSTADEN22
UNIVERSITY OF WALES CARDIFF22
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS21
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER21
RUPRECHT KARLS UNIVERSITAET HEIDELBERG21
UMEA UNIVERSITET21
UNIVERSITY OF TAMPERE21
UNIVERSITY OF TURKU21
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER20
TECHNISCHE UNIVERSITAET MUENCHEN20
UNIVERSIDAD AUTONOMA DE MADRID20
UNIVERSITE LIBRE DE BRUXELLES20
UNIVERSITY OF LEICESTER20
EBERHARD KARLS UNIVERSITAET TUEBINGEN19
INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE19
NEDERLANDSE ORGANISATIE VOOR TOEGEPAST NATUURWETENSCHAPPELIJK ONDERZOEK TNO19
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON19
TERVEYDEN JA HYVINVOINNIN LAITOS19
UNIVERSITA DEGLI STUDI DI PADOVA19
UNIVERSITA DEGLI STUDI DI TORINO19
UNIVERSITY OF SOUTHAMPTON19
ACADEMISCH ZIEKENHUIS GRONINGEN18
DANMARKS TEKNISKE UNIVERSITET18
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR18
GENOME RESEARCH18
STOCKHOLMS UNIVERSITET18
THE UNIVERSITY OF SHEFFIELD18
UNIVERSITAT DE BARCELONA18
UNIVERSITEIT ANTWERPEN18
UNIVERSITY OF AARHUS18
GOETEBORGS UNIVERSITET17
GSFRESEARCH CENTER FOR ENVIRONMENT AND HEALTH17
MEDIZINISCHE UNIVERSITAET WIEN17
TECHNISCHE UNIVERSITAET DRESDEN17
TEL AVIV UNIVERSITY17
THE UNIVERSITY OF LIVERPOOL17
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA17
UNIVERSITE CATHOLIQUE DE LOUVAIN17
UNIVERSITY OF BOLOGNA17
VTT TECHNICAL RESEARCH CENTRE OF FINLAND17
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM16
INSTITUT GUSTAVE ROUSSY16
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT16
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE16
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE16
UNIVERSITAET BASEL16
UNIVERSITAT AUTONOMA DE BARCELONA16
Constancy:

Total number of partners:10686

Partner loyalty:
Frequent Partner: (> 2 projects): 6964
Rare Partner: 3722

Frequent / Rare Partner Ratio: 1.87

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES474
RTD HORIZONTAL TOPICS353
SOCIAL AND ECONOMIC CONCERNS227
PROTECTING MAN AND HIS ENVIRON98
INDUSTRY AND TECHNOLOGY52
AGRICULTURE AND MARINE RESOURC36
ENERGY19
MEASUREMENTS AND STANDARDS12
PHYSICAL AND EXACT SCIENCES9

Project overview:

Start dateProjectacronymrolefundingpartners
2011-05-01Human Brain Project HBPparticipant1.414.38813
2011-02-01Enhancing Human Resources and Use of Appropriate Training for Maternal and Perinatal Survival In Sub-Saharan Africa ETATMBAparticipant2.499.9576
2010-11-01Expanded Quality management Using Information Power for Maternal and Newborn Health in Africa EQUIPcoordinator2.998.4065
2010-11-01Molecular mechanisms of pediatric immunodeficiency syndromes affecting natural killer cell cytotoxicity NK in HLHcoordinator181.6691
2010-09-01Investigation of influenza immune responses and vaccine efficacy correlates by global expression profiling and immunological analyses in the ferret model of influenza FERFLU EXPRESScoordinator239.6931
2010-07-01Developmental Transcription Factors in Dopamine Neuron Maintenance Dopamine Neuron Codecoordinator180.6691
2010-07-01Identification of New Genetic Determinants of Plasma Fibrinogen Concentration INDEFICcoordinator181.6691
2010-07-01Immunomodulatory Effects of Exercise in Type 1 Diabetes IMMEEDIAparticipant399.6005
2008-11-01The antiretroviral roll out for HIV in India - strengthening capacity to promote adherence and patient follow-up in the context HIVINDcoordinator2.946.4206
2008-09-01Nanoparticles for therapy and diagnosis of Alzheimer disease NADparticipant10.921.35019
2007-02-01From gene regulatory networks to drug prediction NET2DRUGparticipant2.981.0009
2007-01-01Health-promotion through obesity prevention across Europe (hope): an integrated analysis to support European health policy HOPEparticipant1.061.2727
2007-01-01Development of optimised recombinant idiotypic vaccines for subset-specific immunotherapy of B cell lymphomas VITALparticipant2.050.5008
2006-11-01Chromatin Immuno-Linked Ligation [ChILL]: A novel generation of biotechnological tools for research and diagnosis CHILLparticipant1.800.4806
2006-10-01Novel prevention and treatment possibilities for Otitis Media through the comprehensive identification of antigenic proteins OMVACparticipant2.321.0007
2006-10-01Polymorphic variations in apoptotic genes and cancer predisposition INTAS 2005-1000008-participant150.0005
2006-06-01Analysis of the alternatively spliced isoforms of human intersectin 1 and 2: characterization of their expression patterns in normal and tumour tissues INTAS 2005-1000004-participant150.0004
2006-06-01Viral polymorphisms and clinical course of human Hepatitis C virus infection INTAS 2005-1000004-coordinator150.0005
2006-05-01The role of peroxiredoxin V in antioxidant defence, apoptosis and regulation of transcription INTAS 2005-1000004-coordinator147.3003
2006-01-01Presence: Research Encompassing Sensory Enhancement, Neuroscience, Cerebral-Computer Interfaces and Applications PRESENCCIAparticipant6.400.00014
2005-02-01Policy-oriented and harmonising research activities in the field of primary immunodeficiency diseases (PIDs) EURO-POLICY-PIDcoordinator1.879.8007
2004-10-06Macromolecule levitation test method LEVMACcoordinator665.4995
2004-09-01Not I microarrays for identification of new cancer-causing genes. coordinator133.1257
2004-09-01Not I micro-arrays for identification of new cancer-causing genes INTAS 2003-51-4983coordinator133.1257
2004-03-01EFFECTS OF THE EXPOSURE TO ELECTROMAGNETIC FIELDS: FROM SCIENCE TO PUBLIC HEALTH EMF-NETparticipant1.534.99439
2004-01-01The fusion of neuroscience and robotics for augmenting human capabilities NEUROBOTICSparticipant5.640.00017
2004-01-01Semantic Interoperability and Data Mining in Biomedicine SEMANTICMININGparticipant5.000.00023
2003-01-01DNA replication and biotechnological applications REPBIOTECHparticipant1.604.6616
2002-12-01Interplay among mitochondria and p53 family proteins during apoptosis induced by dna damage - a new strategy for cancer therapy IMPALEDcoordinator1.983.5477
2002-11-01Novel gene drug strategy based on hybridisation of functional entities to plasmids. EURO GENE DRUGcoordinator1.589.1434
2002-11-01Semliki forest virus based therapeutic systems SFVECTORSparticipant2.223.9577
2002-05-01Approximately Periodic Representation of Stimuli APERESTparticipant406.0003
2002-01-01Innovative therapeutics for the prototype autoimmune disease, myasthenia gravis IMMUNOTHERAPEUTICSparticipant1.822.9848
2001-11-01Suicide gene therapy in stem cell transplantation SGT IN SCTparticipant2.660.40013
2001-01-01Cellular production of human recombinant collagens, gelatins, laminins and growth factors and their use in vascular grafts and other applications MATRIX GRAFTSparticipant1.787.2816
2001-01-01Functional characterisation of orphan g protein-coupled receptors and their validation as drug targets ORPHAN RECEPTORSparticipant1.484.3685
2000-10-01Functional analysis of specific hnrnp proteins in balbiani-ring pre-mrnp particles FOMPROIX NATHALIEcoordinator142.4841
2000-02-01Antigen presentation by chaperon proteins and cd4+ t cell specific help for a new and efficient strategy of cancer vaccination. NEW CANCER VACCINESparticipant2.399.7298
2000-02-01The c-ret receptor tyrosine kinase as a target for drug discovery C-RET DRUG DISCOVERYcoordinator1.244.0004
2000-01-01X-ray structure analysis of pullulanases from hyperthermophilic archaea and bacteria JOYCE HELEN GERALDINcoordinator142.3841

Alias institution names:
  • KAROLINSKA INSTITUTE
  • KAROLINSKA INSTITUTET

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum